SK Capital Partners controlled Apotex files TSX IPO and secondary offering
Apotex Health Corp. has filed a preliminary base PREP prospectus for the proposed initial public offering of its common shares. The offering will include a treasury offering by Apotex and a secondary offering of common shares by certain shareholders, including SK Capital Partners, the company's controlling shareholder. The selling shareholders also include Fonds de solidarité FTQ, Jacesa Investments Ltd., Arlington…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
